Schedule 13G ownership disclosure
PTC Therapeutics Inc
Security class unavailable · CUSIP: 69366J200
Event date: 2018-07-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,328,463
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-040470
- Form type
- SC 13G
- Filer
- D. E. SHAW & CO, L.P.
- CIK
- CIK 1009268
- Filed
- Jul 27, 2018
- Reporting period
- Jul 17, 2018
- Description
- Schedule 13G beneficial ownership